Association of BMI With Benefit of Metformin Plus Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Patients With Advanced Lung Adenocarcinoma: A Secondary Analysis of a Phase 2 Randomized Clinical Trial.
JAMA Oncol
; 8(3): 477-479, 2022 03 01.
Article
en En
| MEDLINE
| ID: mdl-35024769
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Adenocarcinoma del Pulmón
/
Neoplasias Pulmonares
/
Metformina
Tipo de estudio:
Clinical_trials
/
Risk_factors_studies
Límite:
Humans
Idioma:
En
Revista:
JAMA Oncol
Año:
2022
Tipo del documento:
Article